Back

Selective beta blockers are beneficial for chronic obstructive pulmonary disease patients with acute myocardial infarction: a nationwide study of 186,326 patients

26 May 2019 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Coronary Artery Disease Treatment HFA Premium Access Heart Failure 2019

About the speaker

Photo
Doctor Wen-Hwa Wang

Kaohsiung Veterans General Hospital, Kaohsiung (Taiwan)

9 More presentations in this session

Presentation thumbnail
Doctor T. Taeger (Heidelberg, DE)
Abstract
Presentation thumbnail
Doctor G. Tzanis (Athens, GR)
Abstract Slides
Presentation thumbnail
Professor C. Park (Seoul, KR)
Abstract
Presentation thumbnail
Presentation thumbnail
Associate Professor L. Savic (Belgrade, RS)
Abstract

Access the full session

Session thumbnail
Poster Session 2 - Coronary Artery Disease

The Event

Event poster

Heart Failure 2019

26 May 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Beta-blockers in patients with heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: cardiovascular and respiratory outcomes
19 May 2025
thumbnail
Congress Presentation
Beta-blocker therapy and angina pectoris after myocardial infarction: a BETAMI-DANBLOCK substudy
23 April 2026
thumbnail
Congress Presentation
Features and risk factors for the development of acute myocardial infarction in patients with chronic obstructive pulmonary disease, depending on the severity
29 June 2021
thumbnail
Congress Presentation
Long-term outcomes of beta-blocker use in elderly patients without left ventricular systolic dysfunction after percutaneous coronary intervention for acute myocardial infarction
26 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources